Torrent Pharmaceuticals Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Trivoglitor 1 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Trivoglitor 1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Trivoglitor 1 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Trivoglitor 1 Tablet SR.
Trivoglitor 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Trivoglitor 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Trivoglitor 1 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. Carry a sugar source with you for immediate relief in case of hypoglycemia (low blood sugar level). Your doctor may check your liver function regularly.
Triveglitor 1 Tablet SR contains Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM). This medicine improves blood glucose levels in adults when combined with diet and exercise. Glimepiride reduces blood glucose by enhancing insulin release from the pancreas. Metformin decreases glucose production in the liver and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, lowers postprandial (after meal) glucose levels.
Possible side effects of Trivoglitor 1 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Avoid use of Trivoglitor 1 Tablet SR if you have known allergies to the medication's ingredients or excipients. Also, avoid use if you suffer from moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No. Combining Trivoglitor 1 Tablet SR with alcohol may lower blood sugar levels and increase the risk of lactic acidosis.
Yes, using Trivoglitor 1 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and anxiety or shakiness. It is more likely to occur if you miss meals, drink alcohol, exercise heavily, or take other diabetes medications together.
Store this medicine in its original packaging. Close it tightly. Do not store it near heat sources. Dispose of any unused medication according to your local regulations.